⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 28, 2026Molecular Imaging and Radionuclide TherapyOpen Access

PET/CT Identifies Pubic Melorheostosis with High 68Ga-PSMA Uptake in a Patient with Prostate Cancer

Deya' Aldeen Sweedat Ahmed Saad Abdlkadir Akram Al-Ibraheem

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate the potential of Ga-PSMA PET/CT in diagnosing melorheostosis.
Utilized Ga-PSMA PET/CT imaging to assess melorheostosis.
Focused on patients with prostate cancer.
Ga-PSMA PET/CT successfully identified pubic melorheostosis.
High uptake of 68Ga-PSMA was observed in affected areas.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Evaluates 68Ga-PSMA uptake in melorheostosis in prostate cancer patients, suggesting diagnostic potential.

Abstract

Ga-PSMA PET/CT may have a role in the evaluation of melorheostosis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sweedat et al. (2026) studied this question.

synapsesocial.com/papers/69f444d3967e944ac5567a02 https://doi.org/10.4274/mirt.galenos.2026.62144

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prostate-specific Membrane Antigen–PET/CT in Nonprostatic MalignanciesReview · 2025
2Intramuscular Granular Cell Tumor Detected on 68Ga-PSMA PET/CT2024
3Atypical neoplastic solitary focal uptake of 18F-PSMA-1007 in PET/CT in patients with biochemically recurrent prostate cancer2024
4[<sup>68</sup>Ga]Ga-PSMA-11 PET/CT–Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging2024
5The added value of 68Ga-PSMA PET/CT in anatomical staging of prostatic carcinoma in correlation with the histopathological zonal staging2024

Triple Tumors Uncovered: Insights from 2025
<sup>68</sup>Ga Prostate-specific Membrane Antigen Uptake in Metastatic Medullary Thyroid Carcinoma2024
Paget’s Disease Mimicking Prostate Cancer Metastasis with 68Ga-PSMA PET/CT2024
Papillary Thyroid Microcarcinomas Detected by Nuclear Medicine Imaging: Distinct Clinicopathological Features Compared with Conventional ModalitiesMolecular Imaging and Radionuclide Therapy · 2026
Combined Maximum Tolerated Activity and Lesion-based Dosimetry for Personalized Radioiodine Therapy in Metastatic Differentiated Thyroid Carcinoma: An Early Institutional ExperienceMolecular Imaging and Radionuclide Therapy · 2026

More from Molecular Imaging and Radionuclide Therapy

More from Itron (United States)

More from King Hussein Cancer Center